[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351990-105":59,"doc-detail-351990-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","s1-4-aptamer-mediated-iron-oxide-nanoparticles-for-targeted-magnetic-hyperthermia-in-mcf-7-breast-cancer-cells-s1-4-develop-and-evaluate","S1-4 aptamer-mediated iron oxide nanoparticles for targeted magnetic hyperthermia in MCF-7 breast cancer cells - S1-4 - develop and evaluate","","Objective: develop S1-4 aptamer-conjugated citric acid-coated Fe3O4 nanoparticles and assess targeting ability and magnetic hyperthermia against MCF-7 breast cancer cells. Methods: synthesize citric acid-coated Fe3O4 by chemical co-precipitation, conjugate with S1-4 aptamer, then characterize by XRD, TEM, DLS, zeta potential, FTIR, and VSM. Evaluate biocompatibility, cellular uptake, and hyperthermia under alternating magnetic fields via viability, live/dead, and apoptosis assays. Results show enhanced targeting and greater hyperthermia, reducing proliferation and increasing apoptosis with low cytotoxicity.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/s1-4-aptamer-mediated-iron-oxide-nanoparticles-for-targeted-magnetic-hyperthermia-in-mcf-7-breast-cancer-cells-s1-4-develop-and-evaluate/351990/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/s1-4-aptamer-mediated-iron-oxide-nanoparticles-for-targeted-magnetic-hyperthermia-in-mcf-7-breast-cancer-cells-s1-4-develop-and-evaluate/351990.png","ImageObject",300,407,{"name":92,"@type":93},"Guten tag","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the study objective for the S1-4 aptamer-conjugated nanoparticles?","Question",{"text":113,"@type":114},"To develop S1-4 aptamer-conjugated citric acid-coated Fe3O4 nanoparticles and evaluate their targeting capability and magnetic hyperthermia effect against MCF-7 breast cancer cells.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were the nanoparticles synthesized and verified?",{"text":118,"@type":114},"Citric acid-coated Fe3O4 nanoparticles were synthesized by chemical co-precipitation, then conjugated with the S1-4 aptamer. Characterization used X-ray diffraction, transmission electron microscopy, dynamic light scattering, zeta potential, FTIR, and vibrating sample magnetometry.",{"name":120,"@type":111,"acceptedAnswer":121},"What biological outcomes were observed under alternating magnetic field exposure?",{"text":122,"@type":114},"S1-4 aptamer-conjugated nanoparticles produced a significantly greater hyperthermia effect than controls, resulting in reduced cell proliferation and increased apoptosis in MCF-7 cells.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351990,1790134994,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","S1-4 aptamer-mediated iron oxide nanoparticles for targeted magnetic hyperthermia in MCF-7 breast cancer cells  \nJournal of International Medical Research 2026, Vol. 54(7) 1–11 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03000605261464285](DOI: 10.1177/03000605261464285)[ ](DOI: 10.1177/03000605261464285)[journals.sagepub.com/home/imr](journals.sagepub.com/home/imr)  \nEnyuan Chen 1,* , Yu Yin 1,*, Xiaoyun Miao 1, Bin Yu 1, Jun Yang 1, Mingming Li 1, Xiaoyun Wang 1 and Caifang Ni 1  \nAbstract  \nObjective: To develop S1-4 aptamer-conjugated citric acid-coated Fe3O4 nanoparticles and evaluate their targeting ability and magnetic hyperthermia effect against MCF-7 breast cancer cells.  \nMethods: Citric acid-coated Fe3O4 nanoparticles were synthesized by chemical co-precipitation and subsequently conjugated with the S1-4 aptamer to fabricate S1-4 aptamer-conjugated citric acid-coated Fe3O4 nanoparticles. The nanoparticles were characterized by X-ray diffraction, transmission electron microscopy, dynamic light scattering, zeta potential analysis, Fourier transform infrared spectroscopy, and vibrating sample magnetometry. Biocompatibility was assessed in MCF-7 and MEF cells; cellular targeting was examined by Prussian blue staining; and the magnetic hyperthermia effect under an alternating magnetic ﬁeld was evaluated by cell viability, live/dead staining, and apoptosis assays. Results: Compared with citric acid-coated Fe3O4 nanoparticles, S1-4 aptamer-conjugated citric acid-coated Fe3O4 nanoparticles exhibited a larger hydrodynamic diameter (17 ± 4 nm vs. 8 ± 3 nm) and a more negative surface charge (−26.7 ± 0.3 mV vs. −19.7 ± 0.5 mV). Fourier transform infrared spectroscopy conﬁrmed successful aptamer conjugation. Both nanoparticles demonstrated good biocompatibility in MCF-7 and MEF cells. Prussian blue staining demonstrated stronger cellular uptake of S1-4 aptamer-conjugated citric acid-coated Fe3O4 nanoparticles in MCF-7 cells. Under alternating magnetic ﬁeld exposure, S1-4 aptamer-conjugated citric acid-coated Fe3O4 nanoparticles produced a signiﬁcantly greater hyperthermia effect than the controls, resulting in reduced cell proliferation and increased apoptosis in MCF-7 cells (P\u003C0.01). Conclusions: S1-4 aptamer-mediated Fe3O4 nanoparticles demonstrated active targeting ability and enhanced the antitumor effect of alternating magnetic ﬁeld–mediated magnetic hyperthermia in breast cancer cells and maintained low cytotoxicity under the tested conditions, suggesting that they may be a feasible platform for targeted magnetic hyperthermia.  \nKeywords  \nMagnetic hyperthermia, iron oxide nanoparticles, aptamer-mediated targeting, MCF-7 cells, breast cancer, apoptosis  \nReceived: 17 November 2025; accepted: 12 June 2026  \n1 Department of Interventional Radiology, First Afﬁliated Hospital of Soochow University, China  \n*These authors contributed equally to this work.  \nCorresponding authors:  \nCaifang Ni, Department of Interventional Radiology, First Afﬁliated Hospital of Soochow University, Suzhou, Jiangsu 215000, P.R. China.  \nEmail: [cjr.nicaifang@vip.163.com](cjr.nicaifang@vip.163.com)  \nXiaoyun Wang, Department of Interventional Radiology, First Afﬁliated Hospital of Soochow University, Suzhou, Jiangsu 215000, P.R. China.  \nEmail: [616553625@qq.com](616553625@qq.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution  \nNonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as speciﬁed on the SAGE and Open Access page ([https://us](https://us). [sagepub.com/en-us/nam/open-access-at-sage](sagepub.com/en-us/nam/open-access-at-sage)","cbCaifUkhkvmGZ4x","https://ap.wps.com/l/cbCaifUkhkvmGZ4x","pdf",1684187,11,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the study objective for the S1-4 aptamer-conjugated nanoparticles?\",\"answer\":\"To develop S1-4 aptamer-conjugated citric acid-coated Fe3O4 nanoparticles and evaluate their targeting capability and magnetic hyperthermia effect against MCF-7 breast cancer cells.\"},{\"question\":\"How were the nanoparticles synthesized and verified?\",\"answer\":\"Citric acid-coated Fe3O4 nanoparticles were synthesized by chemical co-precipitation, then conjugated with the S1-4 aptamer. Characterization used X-ray diffraction, transmission electron microscopy, dynamic light scattering, zeta potential, FTIR, and vibrating sample magnetometry.\"},{\"question\":\"What biological outcomes were observed under alternating magnetic field exposure?\",\"answer\":\"S1-4 aptamer-conjugated nanoparticles produced a significantly greater hyperthermia effect than controls, resulting in reduced cell proliferation and increased apoptosis in MCF-7 cells.\"}]","S1-4 aptamer-mediated iron oxide nanoparticles for targeted magnetic hyperthermia in MCF-7 breast cancer cells - S1-4 - develop and evaluate | PDF",1790096706,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3cbf084ec5047007888682bed4b90856.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4934e3c625983d39a9de195a9b35858f.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4fbdaa4db379abb1d4e063c21777caa.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/802abe1e164b41e8a81f19458627a9f1.webp",980,1306]